In 2015, drugs that were licensed as branded generics accounted for almost 79 percent of cardiovascular pharmaceutical sales in the Philippines. Cardiovascular diseases are the leading causes of death in the Philippines. In 2017, there were approximately 51 thousand deaths due to ischaemic heart disease in the Philippines.
Market share of licenses in the cardiovascular pharmaceutical sales in the Philippines from 2007 to 2015, by type
According the Philippine domestic pharmaceutical market is segmented into three license types of drugs:
(1) originators; (2) branded generics; and (3) unbranded generics. IQVIA defines originators as those drugs that are first to launch within a single or combined molecule. Meanwhile, branded generics, have the same molecule as the originator. Unbranded generics are those that carry the name of the molecule followed by its manufacturer.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
PCC. (June 8, 2020). Market share of licenses in the cardiovascular pharmaceutical sales in the Philippines from 2007 to 2015, by type [Graph]. In Statista. Retrieved November 10, 2024, from https://www-statista-com.ezproxy.canberra.edu.au/statistics/1196445/philippines-market-share-of-licenses-in-cardiovascular-drug-by-type/
PCC. "Market share of licenses in the cardiovascular pharmaceutical sales in the Philippines from 2007 to 2015, by type." Chart. June 8, 2020. Statista. Accessed November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/1196445/philippines-market-share-of-licenses-in-cardiovascular-drug-by-type/
PCC. (2020). Market share of licenses in the cardiovascular pharmaceutical sales in the Philippines from 2007 to 2015, by type. Statista. Statista Inc.. Accessed: November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/1196445/philippines-market-share-of-licenses-in-cardiovascular-drug-by-type/
PCC. "Market Share of Licenses in The Cardiovascular Pharmaceutical Sales in The Philippines from 2007 to 2015, by Type." Statista, Statista Inc., 8 Jun 2020, https://www-statista-com.ezproxy.canberra.edu.au/statistics/1196445/philippines-market-share-of-licenses-in-cardiovascular-drug-by-type/
PCC, Market share of licenses in the cardiovascular pharmaceutical sales in the Philippines from 2007 to 2015, by type Statista, https://www-statista-com.ezproxy.canberra.edu.au/statistics/1196445/philippines-market-share-of-licenses-in-cardiovascular-drug-by-type/ (last visited November 10, 2024)
Market share of licenses in the cardiovascular pharmaceutical sales in the Philippines from 2007 to 2015, by type [Graph], PCC, June 8, 2020. [Online]. Available: https://www-statista-com.ezproxy.canberra.edu.au/statistics/1196445/philippines-market-share-of-licenses-in-cardiovascular-drug-by-type/
